we have compared the growth and tumor-directed cytotoxic efficacy of recombinant-interleukin-2- ( ril-2 ) -activated peripheral blood ( pbl ) and tumor-infiltrating lymphocytes ( til ) from patients with epithelial ovarian carcinoma .
C0229664
peripheral blood
C1518997
pbl